# Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry

**Bill ID:** S3350
**Session:** 2023
**Sponsor:** Nathalia Fernandez
**Status:** In Senate Committee

## Summary

Requires practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  3350
 
  2023-2024 Regular Sessions
 
  I N  S E N A T E
 
  January 30, 2023
  ___________
 
 Introduced by Sen. FERNANDEZ -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health
 
 AN  ACT to amend the public health law, in relation to requiring practi-
  tioners who administer naloxone or another overdose reversal agent  to
  a  patient  in the case of a suspected or confirmed overdose to report
  the administration of the agent to the prescription monitoring program
  registry
 
  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section 1. Subdivision 9 of section 3343-a of the public health law is
 renumbered  subdivision  10  and a new subdivision 9 is added to read as
 follows:
  9. ADMINISTRATION OF OVERDOSE REVERSAL AGENTS.  (A)  ANY  PRACTITIONER
 WHO ADMINISTERS NALOXONE OR ANOTHER OVERDOSE REVERSAL AGENT TO A PATIENT
 IN THE CASE OF A SUSPECTED OR CONFIRMED OVERDOSE SHALL REPORT THE ADMIN-
 ISTRATION  OF  THE AGENT TO THE PRESCRIPTION MONITORING PROGRAM REGISTRY
 WITHIN SEVENTY-TWO HOURS OF ADMINISTRATION. SUCH  REPORT  SHALL  CONTAIN
 THE  FOLLOWING  INFORMATION  IF  AVAILABLE: (I) THE NAME OF THE PATIENT;
 (II) THE ADDRESS OF THE PATIENT; (III) THE DATE OF BIRTH OF THE PATIENT;
 (IV) THE TIME AND PLACE OF THE ADMINISTRATION OF THE AGENT; AND (V)  THE
 IDENTITY OF THE PERSON WHO ADMINISTERED THE NALOXONE TO THE PATIENT.
  (B) ANY REPORT MADE PURSUANT TO THE TERMS OF THIS SUBDIVISION SHALL BE
 CONSIDERED TO BE MADE BY THE REPORTER IN THE COURSE OF HIS OR HER DUTIES
 AND SHALL BE DIRECTLY RELATED TO PATIENT CARE.
  ยง 2. This act shall take effect January 1, 2025.
 
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD08239-01-3